SCA
CLB icon

Stonebridge Capital Advisors’s Core Laboratories CLB Stock Holding History

Stonebridge Capital Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,800
Closed -$37K – 275
2020
Q2 		$37K Hold
1,800
– – 0.01% 316
2020
Q1 		$19K Buy
1,800
+300
+20% +$8.39K ﹤0.01% 392
2019
Q4 		$57K Buy
1,500
+500
+50% +$22.5K 0.01% 304
2019
Q3 		$47K Buy
1,000
+400
+67% +$18.6K 0.01% 328
2019
Q2 		$31K Buy
+600
New +$35.2K 0.01% 393

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Stonebridge Capital Advisors's CLB Position: Q3 2020 in Review

Stonebridge Capital Advisors sold out of Core Laboratories (CLB) in Q3 2020, closing a stake of 1,800 shares — an estimated $37K sold.

Stonebridge Capital Advisors first reported a position in CLB in Q2 2019 and held it in 5 quarters. The position peaked at $57K in Q4 2019. 187 funds tracked by Wall St. Rank hold CLB as of Q3 2020.

  • Stonebridge Capital Advisors reported no remaining Core Laboratories position as of Q3 2020 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 1,800 Core Laboratories shares in Q3 2020, an estimated $37K.
  • Stonebridge Capital Advisors first reported a position in Core Laboratories in Q2 2019 and held it in 5 quarters.
  • Stonebridge Capital Advisors's Core Laboratories position peaked at $57K in Q4 2019.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2020.

Based on Stonebridge Capital Advisors's 13F filing for Q3 2020, filed 18 Nov 2020.